Publications
- RUNX1 mutations contribute to the progression of MDS due to disruption of antitumor cellular defense: a study on patients with lower-risk MDS2022 | Faculty of Science, First Faculty of Medicine
- Hematopoietic stem cells of lower-risk MDS patients with rapid progression show quiescent-like cell state similar to that of higher-risk MDS cellsPublication without faculty affiliation
- Aging-Related Gene Expression Signatures Define Likelihood of Disease Progression in Patients with Lower-Risk Myelodysplastic SyndromesPublication without faculty affiliation
- Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B12023 | Central Library of Charles University, Faculty of Science
- Modulation of the Immune Response by Deferasirox in Myelodysplastic Syndrome Patients2021 | First Faculty of Medicine
- Low Plasma Citrate Levels and Specific Transcriptional Signatures Associated with Quiescence of CD34(+) Progenitors Predict Azacitidine Therapy Failure in MDS/AML Patients2021 | First Faculty of Medicine
- Circulating Small Noncoding RNAs Have Specific Expression Patterns in Plasma and Extracellular Vesicles in Myelodysplastic Syndromes and Are Predictive of Patient Outcome2020 | Central Library of Charles University, Faculty of Science, First Faculty of Medicine
- LncRNA Profiling Reveals That the Deregulation of H19, WT1-AS, TCL6, and LEF1-AS1 Is Associated with Higher-Risk Myelodysplastic Syndrome2020 | Faculty of Science, First Faculty of Medicine
- The Impact of Next Generation Sequencing on MDS2020 | Central Library of Charles University
- Upregulation of ZEB1-Derived Circular RNAs Is Associated with SF3B1-Mutated Myelodysplastic NeoplasmsPublication without faculty affiliation
Loading network view...